Industry: Pharmaceuticals, Biotechnology
Mirus Bio Corporation is a leader in the emerging fields of gene therapy and RNA interference, based upon its expertise in nucleic acid chemistry and delivery. The company currently markets state-of-the-art DNA and siRNA transfection and labeling products to researchers worldwide. In addition, the company is developing novel human therapeutics enabled by its proprietary Pathway IVÔ delivery platform. The company’s lead therapeutic is a treatment for Muscular Dystrophy, which is being developed collaboratively with Transgene S.A. of Strasbourg, France. ( www.mirusbio.com )
Mirus Bio Corporation
505 South Rosa Road Suite 104
Madison, Wisconsin 53719
USA
Tel: (608) 238-4400